BCL2 and colorectal carcinoma: To investigate whether knockdown of BCL9 and BCL2 counteracts the effects of miR‐140‐3p inhibition on CRC cells, HCT 116 cells were transfected with miR‐140‐3p inhibitor and siRNA of BCL9 or BCL2.